Debut Plus

5.22

+0.14 +2.76%

17 Jul 2026

NSE Listed · Healthcare

Vivimed Labs Limited (VIVIMEDLAB)

Volume: 46,59152W Range:4.9529.4
Market Cap₹44 Cr
Current Price₹5.22
Previous Close₹5.08
High / Low (52w)₹29.4 / ₹4.95
Volume46,591
Avg Vol (1W)
Avg Vol (1M)
Stock P/E
Book Value₹-5.78
Dividend Yield
ROE
ROA
Revenue (TTM)
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value
EPS (TTM)₹-4.21
P/B-0.91
Debt / Equity
50 DMA₹6.13
200 DMA₹7.2
Day change+2.76%
Price Chart
5.22 5.45% · 1Y
25519.2L
2025-07-17
2026-07-15

20-day avg volume: 70K shares

Cons
  • Revenue fell 22% YoY.
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue₹16 Cr₹21 Cr₹21 Cr₹26 Cr₹37 Cr
EBITDA₹-11 Cr₹-1 Cr₹0 Cr₹1 Cr₹1 Cr
Net Profit₹-17 Cr₹-7 Cr₹-5 Cr₹-6 Cr₹-6 Cr
EPS-2-0.88-0.66-0.72
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹116 Cr₹149 Cr₹187 Cr₹237 Cr
EBITDA₹-10 Cr₹-25 Cr₹-187 Cr₹-8 Cr
Net Profit₹-32 Cr₹-45 Cr₹-329 Cr₹-68 Cr
EPS-3.85-5.48-39.62-8.16
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹921 Cr₹951 Cr₹995 Cr₹1,266 Cr
Total Liabilities₹956 Cr₹956 Cr₹956 Cr₹902 Cr
Equity₹-35 Cr₹-5 Cr₹39 Cr₹364 Cr
Total Debt₹376 Cr₹379 Cr₹381 Cr₹359 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022
Operating₹-2 Cr₹-24 Cr₹35 Cr₹28 Cr
Investing₹-5 Cr₹28 Cr₹-5 Cr₹-16 Cr
Financing₹5 Cr₹-6 Cr₹-34 Cr₹-10 Cr
Free Cash Flow₹-6 Cr₹-26 Cr₹30 Cr₹11 Cr
Shareholding
Promoter 14.92% Institutions 9.37% Public 75.71%
About Vivimed Labs Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

www.vivimedlabs.com
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search